Retrospective single-center Rwanda cohort reports treatment gaps and survival estimates
A retrospective cohort of 163 patients treated at one Rwandan cancer center reported estimated median overall survival of 3.68 years ...
A retrospective cohort of 163 patients treated at one Rwandan cancer center reported estimated median overall survival of 3.68 years ...
A simulation study couples a chaotic three-dimensional tumor growth model with an advanced filtering technique to estimate tumor, host, and ...
Epstein-Barr virus-associated gastric cancer (EBVaGC) has long been regarded as the most immunologically favorable form of a disease that remains ...
A new economic evaluation published in BMC Health Services Research concludes that ivonescimab plus chemotherapy, an emerging first-line option for ...
An ancillary analysis of the Japanese phase III trial JCOG1013 found that a tumor proportion score of at least 1% ...
A real-world cohort study of 327 patients with EGFR-mutated non-small cell lung cancer finds that continuing EGFR-TKI therapy plus anti-angiogenic ...
Salk Institute researchers have demonstrated that inducing mild mitochondrial stress during embryonic development in mice confers long-term protection against chemotherapy-induced ...
A subgroup analysis of the phase 3 RASolute 302 trial presented at ESMO found the targeted RAS inhibitor daraxonrasib extended ...
Trinity College Dublin researchers found that Inhibitor of Apoptosis Proteins let tumour cells survive chemotherapy, enter premature senescence and recruit ...
A longitudinal study of 77 hospitalized patients with gastrointestinal, lung, or head and neck cancer found that energy and protein ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine